Patents for A61P 33 - Antiparasitic agents (21,787)
05/2009
05/21/2009US20090130149 Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites
05/21/2009US20090130136 Chondroitin Sulphate a Binding Domains
05/20/2009DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists
05/20/2009CN101434951A Method for obtaining wire-worm microsome amino peptidase gene and use thereof
05/20/2009CN101433552A External-use medicament for treating psora
05/20/2009CN101433531A Use of substance formaldehyde in preparing medicament for coccidiosis of animal
05/20/2009CN101433516A Arteannuin transdermal patch substrate, preparation method and arteannuin transdermal patch thereof
05/20/2009CN100488514C Slowly released solid ivermectin microballoon preparation
05/20/2009CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments
05/19/2009US7534871 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
05/19/2009CA2468879C Substituted cyclohexane derivatives
05/19/2009CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them
05/19/2009CA2333680C Semi-solid aqueous preparations for oral applications of toltrazuril sulphone
05/14/2009WO2009061407A1 Schistosoma vaccine
05/14/2009WO2009060445A1 Synthetic sphingolipid analogs
05/14/2009WO2009060063A1 Anthelmintic combination
05/14/2009WO2009059435A1 Avenanthramide-containing compositions
05/14/2009WO2009059409A1 Biomarkers for visceral leishmaniasis
05/14/2009WO2009039102A8 Inhibitors of copn (cpn) for the treatment of bacterial infections
05/14/2009US20090124554 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
05/14/2009DE102007054049A1 System for drug transport into trypanosomal cells comprises a ktenate matrix with targeting molecules in the form of antibody Fc fragments
05/14/2009CA2704380A1 Avenanthramide-containing compositions
05/13/2009EP2058658A2 Method and means for influencing intercellular communication and intercellular organelle transport
05/13/2009EP2058399A1 Methods and reagents for vaccination which generate a CD8 T cell immune response
05/13/2009EP2057165A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
05/13/2009EP2056806A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins
05/13/2009EP1385525B1 Targeted oxidative therapeutic formulation
05/13/2009CN101429182A Anti-ameba protozoon disease compounds of 8-Epigroshiemin and synthesis thereof
05/13/2009CN101428085A Insecticide for animal
05/13/2009CN100486576C Substituted pyridinones as modulators of P38MAP kinase
05/12/2009CA2272338C Immunization of infants
05/12/2009CA2109977C Giardia vaccines
05/07/2009WO2009058859A2 Dispiro 1,2,4-trioxolane antimalarials
05/07/2009US20090118298 Octahydropentalene compounds as chemokine receptor antagonists
05/07/2009US20090118219 Flea gaba receptor subunit nucleic acid molecules
05/07/2009US20090117193 Compositions Comprising an Active Agent
05/07/2009US20090117139 Lutzomyia longipalpis polypeptides and methods of use
05/07/2009US20090117037 Methods Of Treatment Using CTLA-4 Antibodies
05/07/2009CA2702256A1 Dispiro 1,2,4-trioxolane antimalarials
05/06/2009EP2054064A2 Transdermal application of triazines for controlling coccidia infections
05/06/2009CN101422620A Cryptosporidum parvum bivalent nucleic acid vaccine and preparation method thereof
05/06/2009CN101422605A Immunoloregulation type DNA vaccine capable of preventing Eimeria necatrix
05/06/2009CN101422604A Immunoloregulation type DNA vaccine capable of preventing Eimeria acervulina
05/06/2009CN101422516A Traditional Chinese medicine oral liquid for treating chicken coccidiosis
05/06/2009CN101422476A Animal compound sodium closantel injection
05/05/2009CA2610100A1 Methods and compositions for treating and preventing malaria
05/05/2009CA2606624A1 Methods and compositions for treating and preventing malaria (2)
04/2009
04/30/2009WO2009053758A1 Anti-malarial pharmaceutical composition
04/30/2009WO2009053466A1 Long acting injectable formulations
04/30/2009WO2009052566A1 Anti-microbial composition
04/30/2009WO2009032773A3 Compositions and methods for treating demodex infestations
04/30/2009WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling
04/30/2009US20090110696 Mycobacterial SecA2 Mutants
04/30/2009CA2703299A1 Anti-microbial composition
04/30/2009CA2702800A1 Long acting injectable formulations
04/30/2009CA2702506A1 Anti-malarial pharmaceutical composition
04/29/2009EP1841437B1 9a-carbamoyl and thiocarbamoyl azalides with antimalarial activity
04/29/2009EP1791813B1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds
04/29/2009EP1454136B1 Methods and means for influencing intracellular communication and intracellular organelle transport
04/29/2009CN101418309A Cloning, expression and application of eimeria tenella protein disulfide isomerase gene
04/29/2009CN101416973A Preparation method of novel composite anti-coccidium, antibiotic preparation
04/29/2009CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
04/29/2009CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers
04/28/2009US7524828 Immunostimulatory nucleic acid molecules
04/23/2009WO2009051796A2 2,5-diaryl selenophene compounds, aza 2,5-diaryl thiophene compounds, and their prodrugs as antiprotozoal agents
04/23/2009US20090105287 Inhibitors of Dihydrofolate Reductase With Antibacterial Antiprotozoal, Antifungal and Anticancer Properties
04/23/2009US20090104219 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen
04/22/2009EP2050815A1 Streptomyces Avermitilis gene directing the ratio of B2:B1 avermectins
04/22/2009EP2049112A2 Treating infections and sequelae thereof with combined dissociated glucocorticoid receptor agonists and anti-infective agents
04/22/2009EP1715883B1 18-membered nitrobenzyl-substituted and aminobenzyl-substituted cyclohexadepsipeptides for controlling endoparasites, and method for the production thereof
04/21/2009US7521569 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activities
04/21/2009US7521476 Aminoacetonitrile derivatives suitable for controlling parasites
04/21/2009US7521440 Targeted oxidative therapeutic formulation
04/21/2009US7521429 each case in free form or in salt form; pesticidal compositions in which the active ingredient has been selected from those compounds and their tautomers; and a method of controlling pests using those compositions are described.** Image-1
04/21/2009CA2400317C Improved paste formulations
04/16/2009WO2008062431A3 Synergistic anthelmintic composition
04/16/2009US20090099220 Antimalarial compounds with flexible side-chains
04/16/2009CA2700880A1 Antimalarial compounds with flexible side-chains
04/15/2009EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
04/15/2009EP2047850A2 Methods for treating diseases through inhibition of the function of molecular chaperones such as protein disulfide isomerases , pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
04/15/2009EP2046739A1 Substituted aniline derivatives
04/15/2009EP2046339A1 Rho/rock/p13/akt kinase inhibitors for the treatment of diseases associated with protozoan parasites
04/15/2009EP1432680B1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
04/15/2009CN101410372A Novel lactams
04/15/2009CN101410367A Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
04/15/2009CN101407499A Triazine compounds having coccidiostat activity and preparation thereof
04/15/2009CN101406696A Vaccine comprising a tick cement protein
04/15/2009CN101406648A Powder for destroying parasites and relieving itching containing Radix stemonae, pepper and Sophora flavescens
04/15/2009CN101406453A Pharmaceutical compositions for oral and topical administration
04/14/2009US7517883 Solubilized topoisomerase poisons
04/14/2009US7517861 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis
04/14/2009US7517535 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags
04/09/2009WO2009045497A1 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
04/09/2009WO2009044788A1 Benzoxazinone derivative
04/09/2009WO2009043902A1 Bisbenzimidazoles as antimalarial agents
04/09/2009US20090093433 SENSE mRNA THERAPY
04/09/2009US20090092611 Antibodies that bind both bcma and taci
04/09/2009US20090092545 Antibodies that bind both bcma and taci
04/09/2009CA2701778A1 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
04/09/2009CA2701406A1 Benzoxazinone derivative
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 218